Cartesian Therapeutics (RNAC) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Cartesian Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $206K and 3 sold $259K of RNAC stock on the open market.
Get emailed when insiders cluster-buy stocks like RNAC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RNAC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $259K | 3 |
| Q4 2025 | $206K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Cartesian Therapeutics, Inc. insider reported open-market purchases totaling $206K, while 3 insiders reported sales totaling $259K. 0 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jan 8SEC | Carsten BrunnCEO, President | Sell | 23,766323,530 held (−7%) | $6.82 | $162K | +3.4% | — |
| Jan 8SEC | Blaine DavisCFO | Sell | 10,591121,220 held (−8%) | $6.82 | $72K | +3.4% | — |
| Jan 8SEC | Milos MiljkovicChief Medical Officer | Sell | 3,57358,820 held (−6%) | $6.82 | $24K | +3.4% | — |
| Dec 8SEC | Timothy C BarabeDirector | Buy | 30,00054,366 held (+123%) | $6.86 | $206K | +2.8% | — |
Insiders at Cartesian Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Timothy C BarabeDirector | $206K | — | Dec 8, 2025 | — |
| Carsten BrunnCEO, President | — | $162K | Jan 8, 2026 | — |
| Blaine DavisCFO | — | $72K | Jan 8, 2026 | — |
| Milos MiljkovicChief Medical Officer | — | $24K | Jan 8, 2026 | — |
RNAC stock: common questions
Are Cartesian Therapeutics, Inc. insiders buying RNAC stock?
In the past 12 months, 1 insiders reported open-market purchases of RNAC worth $206K. The latest was Director Timothy C Barabe bought $206K of RNAC at $6.86 — first open-market purchase in our records; raises the stake by 123%.
Are Cartesian Therapeutics, Inc. insiders selling RNAC stock?
3 insiders reported sales worth $259K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RNAC's 52-week range?
Over the past year RNAC has traded between $5.84 and $10.59. It last closed at $7.05 on Oct 9, 2026.